Controversies & Advances in the Treatment of Cardiovascular Disease
  • Home
  • CME

Controversies 2017 Online Syllabus

Take the 2017 course evaluation

General Course Materials
Updated 2017 scientific program
General Symposium Information
Faculty Disclosures
PDFs of the faculty presentations will be available below, when approved by the speaker. 

To the best of our ability, PDFs will be posted within 24 hours of presentation.


Thursday, November 16, 2017

Welcome Address - John Harold, MD
Welcome Address from CA ACC - Garwood Gee
How Can We Dislodge CAD as the Nation's #1 Killer? - James Forrester, MD
Session I: Atherosclerosis and Dyslipidemia
PCSK9 Inhibitors - Michael Blaha, MD, MPH
Targeting Inflammation in Atherosclerosis - Sanjay Kaul, MD, MPH
Session II: California Chapter ACC Statellite Symposium: Innovation and Technology
Advances in Digital Medicine - Raj Khandwalla, MD, MA
ACC Innovation - John Harold, MD
Everyone's a Critic - Bill Tancer
The APP-lication of Innovation and Technology - Vinayak Bapat, FRCS, CTh
Session III: STEMI, NSTEMI, Cardiac Arrest
Case Presentation - Sam Dawkins, MD, PhD
Case Presentation - Richard Cheng, MD
New Horizons in Cardiogenic Shock - Timothy D. Henry, MD
YES, We Need EKG Transmission - Ivan C. Rokos, MD
NO, EKG is Not Necessary - Timothy D. Henry, MD
New Horizons in Cardiogenic Shock - Timothy D. Henry, MD
Session IV: Contemporary Controversies in Drugs and Devices
COMPASS Trial - C. Michael Gibson, MD
Does IMPROVE-IT and FOURIER Confirm or Refute the LDL Hypothesis? - Sanjay Kaul, MD, MPH
Session V: Controversies in Advanced Heart Failure
Diastolic Function: Progress in the Treatment of Cardiac Amyloid - Jignesh Patel, MD, PhD
Medical Treatment for Restrictive Cardiomyopathy - Dael Geft, MD
Surgical Treatment for Restrictive Cardiomyopathy - Danny Ramzy, MD, PhD
Session VI: Hypertension
Rise, Fall, and Resurrection of Renal Denervation - Michael A. Weber, MD

Friday, November 17, 2017

Session VII: Electrophysiology
Sudden Death in Athletes - Jacob Tfelt-Hansen, MD, DMSc
Catheter Ablation for Atrial Fibrillation - Francis Marchlinski, MD
His Bundle Pacing - Kenneth Ellenbogen, MD
ICDs for Non-Ischemic Cardiomyopathy - Win Shen, MD
The Cedars-Sinai Heart Institute: A Ten Year Progress Report - Eduardo Marban, MD, PhD
Session VIII: Sex Differences in CVD - Drug and Device Approval and Use
Introduction and Overview - C. Noel Bairey Merz, MD
Example of Sex Differences of Clinical Importance - Viviany Taqueti, MD, MPH
Considerations of Sex Differences in FDA Device Approval - Teri L. Cornelison, MD, PhD
Overview of FDA Review, Approval, Post-Approval Monitoring - Marjorie Jenkins, MD, MEdHP
Session IX: Controversies in Structural Heart Disease
PFO Closure - Ted Feldman, MD
Is It Time for a National Network of Valve Centers? - Michael Mack, MD
What Degree of MR Deserves Surgical or Transcatheter Intervetion - Robert Siegel, MD
Session X: Update in Cardiac Imaging
Coronary Calcium Scan - Matthew Budoff, MD
Coronary CTA - Gilbert Raff, MD
HFPEF - ECHO with Strain vs. MRI T1 Mapping - Erik Schelbert, MD, MS
FFR is NOT the Gold Standard for Revascularization Decision Making - Paul S. Teirstein, MD
FFR IS the Gold Standard for Revascularization Decision Making - Matthew J. Price, MD
Update in Nuclear Imaging of Infiltrative Cardiomyopathy - Balaji Tamarappoo, MD, PhD
Stress SPECT/PET vs. Stress ECHO - Sean Hayes, MD
Stress SPECT/PET vs. Stress ECHO - Charles Pollick, MD
FFR-CT: Not Ready for Prime Time - Leslee Shaw, PhD
Intermediate Lesion on CCTA - Jonathon A. Leipsic, MD
For more information, please contact:
Promedica International CME
300 Carlsbad Village Dr., Ste 108A-326 | Carsbad | CA | 92008
Phone: 760-720-2263 | Fax: 760-720-6263
Email: Rebecca Law, rlaw@promedicacme.com
  • Home
  • CME